Citadel Advisors’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.07M | Sell |
2,955,047
-447,564
| -13% | -$1.22M | ﹤0.01% | 1527 |
|
|
2025
Q1 | $5.72M | Buy |
3,402,611
+2,197,074
| +182% | +$3.69M | ﹤0.01% | 1646 |
|
|
2024
Q4 | $1.97M | Buy |
1,205,537
+1,026,243
| +572% | +$1.67M | ﹤0.01% | 2620 |
|
|
2024
Q3 | $746K | Buy |
179,294
+119,919
| +202% | +$499K | ﹤0.01% | 3380 |
|
|
2024
Q2 | $324K | Sell |
59,375
-1,827,781
| -97% | -$9.98M | ﹤0.01% | 4234 |
|
|
2024
Q1 | $18.9M | Buy |
1,887,156
+1,847,280
| +4,633% | +$18.5M | ﹤0.01% | 915 |
|
|
2023
Q4 | $163K | Sell |
39,876
-245,596
| -86% | -$1M | ﹤0.01% | 4700 |
|
|
2023
Q3 | $1.1M | Buy |
285,472
+166,040
| +139% | +$643K | ﹤0.01% | 2944 |
|
|
2023
Q2 | $712K | Sell |
119,432
-1,469,949
| -92% | -$8.76M | ﹤0.01% | 3304 |
|
|
2023
Q1 | $5.2M | Buy |
1,589,381
+737,578
| +87% | +$2.41M | ﹤0.01% | 1787 |
|
|
2022
Q4 | $3.36M | Sell |
851,803
-335,609
| -28% | -$1.33M | ﹤0.01% | 2143 |
|
|
2022
Q3 | $7.13M | Buy |
1,187,412
+1,119,195
| +1,641% | +$6.72M | ﹤0.01% | 1551 |
|
|
2022
Q2 | $439K | Buy |
68,217
+32,950
| +93% | +$212K | ﹤0.01% | 4271 |
|
|
2022
Q1 | $291K | Sell |
35,267
-163,896
| -82% | -$1.35M | ﹤0.01% | 4963 |
|
|
2021
Q4 | $3.08M | Buy |
+199,163
| New | +$3.08M | ﹤0.01% | 2588 |
|
|
2021
Q3 | – | Sell |
-59,693
| Closed | -$1.17M | – | 6990 |
|
|
2021
Q2 | $1.17M | Sell |
59,693
-51,765
| -46% | -$1.02M | ﹤0.01% | 3812 |
|
|
2021
Q1 | $3.73M | Buy |
+111,458
| New | +$3.73M | ﹤0.01% | 2456 |
|